Key facts
- Conno Christou, a 35-year-old founder, was diagnosed with aggressive non-Hodgkin's lymphoma.
- He gathered 12 medical opinions, with 11 favoring a more aggressive chemotherapy regimen.
- Christou used AI chatbots, including Claude, to analyze his medical data and treatment options.
- AI helped identify a thymus gland reactivation as the cause of a false-positive PET scan result.
- This led to avoiding unnecessary radiotherapy, confirming Christou was cancer-free.
Conno Christou, a founder known for his meticulous health tracking, was diagnosed with an aggressive form of non-Hodgkin's lymphoma at age 35. Despite a clean bill of health just months prior, a routine workout led to the discovery of a large tumor. Faced with conflicting medical advice regarding chemotherapy regimens, Christou leveraged his data-driven approach and professional network to gather twelve opinions, ultimately choosing the more aggressive treatment.
During his six-month chemotherapy, Christou continued to meticulously track his health data, including sleep patterns via wearable devices and symptom logs. He fed this comprehensive data into AI chatbots, such as Claude, to help him understand his condition and treatment options. While experts caution against relying solely on general-purpose chatbots for medical advice, Christou found the AI invaluable for asking the right questions and processing complex medical literature, especially for a rare condition.
At the end of his treatment, an ambiguous PET scan raised concerns about residual disease, potentially requiring further radiotherapy. Christou again turned to AI, which flagged a common phenomenon in younger patients: thymus gland reactivation after chemotherapy, which can mimic active disease on scans. This insight, combined with his age and scan characteristics, led him to seek further opinions, ultimately confirming the thymus rebound and avoiding unnecessary radiation. Christou, who founded Keragon, an AI-powered medical practice automation platform, now emphasizes the immediate potential of AI tools for patients navigating healthcare challenges.